We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$140B
AUM Growth
+$5.41B
Cap. Flow
-$342M
Cap. Flow %
-0.24%
Top 10 Hldgs %
18.35%
Holding
2,924
New
135
Increased
1,612
Reduced
794
Closed
70

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$365M
2
TT icon
Trane Technologies
TT
+$207M
3
TRP icon
TC Energy
TRP
+$163M
4
MRK icon
Merck
MRK
+$158M
5
DIS icon
Walt Disney
DIS
+$158M

Sector Composition

Rank Sector Weight
1 Technology 18.31%
2 Financials 14.07%
3 Healthcare 13.31%
4 Consumer Discretionary 12.06%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACIC icon
2551
American Coastal Insurance
ACIC
$535M
$162K ﹤0.01%
11,372
AVD icon
2552
American Vanguard Corp
AVD
$71.2M
$162K ﹤0.01%
10,522
RUBY
2553
DELISTED
Rubius Therapeutics, Inc
RUBY
$162K ﹤0.01%
+10,300
New +$166K
KPTI icon
2554
Karyopharm Therapeutics
KPTI
$44.4M
$162K ﹤0.01%
1,798
+904
+101% +$72.6K
ENIC icon
2555
Enel Chile
ENIC
$6.22B
$157K ﹤0.01%
32,791
+7,311
+29% +$35.1K
EOLS icon
2556
Evolus
EOLS
$403M
$156K ﹤0.01%
+10,700
New +$212K
IUSG icon
2557
iShares Core S&P US Growth ETF
IUSG
$33.5B
$156K ﹤0.01%
2,495
-333
-12% -$20.5K
EXPR
2558
DELISTED
Express, Inc.
EXPR
$156K ﹤0.01%
2,858
HEZU icon
2559
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$584M
$156K ﹤0.01%
5,063
-1,329
-21% -$40.1K
GGB icon
2560
Gerdau
GGB
$10B
$156K ﹤0.01%
50,400
-6,678
-12% -$19.6K
DGRW icon
2561
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.2B
$155K ﹤0.01%
+3,550
New +$154K
FSM icon
2562
Fortuna Silver Mines
FSM
$2.74B
$155K ﹤0.01%
54,194
RY icon
2563
Royal Bank of Canada
RY
$290B
$153K ﹤0.01%
1,927
ASAP
2564
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$153K ﹤0.01%
+1,215
New +$207K
ASMB icon
2565
Assembly Biosciences
ASMB
$524M
$152K ﹤0.01%
936
LTS
2566
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$149K ﹤0.01%
43,544
IWX icon
2567
iShares Russell Top 200 Value ETF
IWX
$4.05B
$149K ﹤0.01%
2,763
NERV icon
2568
Minerva Neurosciences
NERV
$188M
$149K ﹤0.01%
3,300
REVG
2569
DELISTED
REV Group
REVG
$148K ﹤0.01%
10,300
-13,089
-56% -$160K
CBL
2570
DELISTED
CBL& Associates Properties, Inc.
CBL
$146K ﹤0.01%
140,835
-70,463
-33% -$81.4K
SRNE
2571
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$141K ﹤0.01%
52,896
+14,943
+39% +$53.8K
GERN icon
2572
Geron
GERN
$860M
$140K ﹤0.01%
99,170
AAXJ icon
2573
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.79B
$137K ﹤0.01%
1,969
-437
-18% -$30.3K
EVC icon
2574
Entravision Communication
EVC
$1.07B
$133K ﹤0.01%
42,579
CVEO icon
2575
Civeo
CVEO
$338M
$130K ﹤0.01%
6,302
+3,096
+97% +$66.9K

Similar funds

UBS AM's Q2 2019 Portfolio in Review

As of Q2 2019, UBS AM held 2,924 positions worth $140B, up 4% from $135B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS AM's Q2 2019 filing shows 135 new, 1,612 increased, 794 reduced and 70 closed positions. Its largest new stake was Dow Inc: 2,393,505 shares worth $118M. The largest sale was Microsoft, an estimated $210M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • UBS AM's largest Q2 2019 buy was Dow Inc: 2,393,505 shares worth $118M.
  • UBS AM added most to Alibaba in Q2 2019, an estimated $365M increase.
  • UBS AM's biggest Q2 2019 reduction was Microsoft, cutting an estimated $210M.
  • UBS AM fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $18.2M.
  • UBS AM's ten largest holdings make up 18% of its $140B portfolio in Q2 2019.
  • UBS AM opened 135 new positions and closed 70 in Q2 2019.
  • UBS AM's portfolio value rose 4% quarter-over-quarter to $140B.

Based on UBS AM's 13F filing for Q2 2019, filed 15 Aug 2019.